For FDA-approved GLP-1 medications, out-of-pocket cost can vary by insurance coverage, diagnosis, plan design, manufacturer savings-card eligibility, pharmacy, and dose
Both medications have similar digestive side effects, and the better option depends on treatment goals, tolerance, and medical guidance
Retatrutide is the unimolecular triple agonist furthest in development and data from phase 2 trials suggests that this may soon become the most potent weight-lowering pharmacotherapy to be licenced
Prioritize Carb Timing to Prevent Hypoglycemia Since IGF-1 increases glucose uptake, you must ensure post-injection carbohydrate intake is adequate
however, these side effects were no different from those observed with subcutaneous semaglutide treatment (64)